Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study

Bitzer, Michael; Horger, Marius; Giannini, Edoardo G.; Ganten, Tom M.; Siveke, Jens T.; Dollinger, Matthias M.; Gerken, Guido; Scheulen, Max E.; Wege, Henning; Zagonel, Vittorina; Cillo, Umberto; Trevisani, Franco; Santoro, Armando; Montesarchio, Vincenzo; Malek, Nisar P.; Holzapfel, Julia; Herz, Thomas; Ammendola, Astrid S.; Pegoraro, Stefano; Hauns, Bernhard; Mais, Anna; Lauer, Ulrich M.; Henning, Stefan W.; Hentsch, Bernd; Wörns, Marcus A.

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study

Autor(en):

Bitzer, Michael; Horger, Marius; Giannini, Edoardo G.; Ganten, Tom M.; Siveke, Jens T.; Dollinger, Matthias M.; Gerken, Guido; Scheulen, Max E.; Wege, Henning; Zagonel, Vittorina; Cillo, Umberto; Trevisani, Franco; Santoro, Armando; Montesarchio, Vincenzo; Malek, Nisar P.; Holzapfel, Julia; Herz, Thomas; Ammendola, Astrid S.; Pegoraro, Stefano; Hauns, Bernhard; Mais, Anna; Lauer, Ulrich M.; Henning, Stefan W.; Hentsch, Bernd; Wörns, Marcus A.

Tübinger Autor(en):

Bitzer, Michael
Horger, Marius Stefan
Malek, Nisar Peter
Lauer, Ulrich Manfred

Erschienen in:

Journal of Hepatology (2016), Bd. 65, H. 2, S. 280-288

Verlagsangabe:

Elsevier Science Bv

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.jhep.2016.02.043

ISSN:

1600-0641